Abortion pill manufacturer asks Supreme Court to hear case on mifepristone access
CBSN
Danco Laboratories, the drugmaker of the abortion pill mifepristone, has asked the Supreme Court to review a lower court's decision limiting access to the pill, the company announced in a news release Friday.
Danco is asking the Supreme Court to reverse an appellate court ruling that would prevent women from obtaining the drug by mail order and would prohibit the pill after seven weeks of pregnancy.
Last month, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit issued a ruling that allowed the pill to remain legal, but with significant hurdles to patient access. The Fifth Circuit upheld the Food and Drug Administration's approval of the widely used pill, but said actions the FDA took in recent years to make the pill easier to obtain went too far.
